interindividual variability and intraindividual variability of antimycotic concentrations in individuals receiving treatment for mycotic infections

Not Applicable

Not yet recruiting

• Conditions: aspergillus infection; mycotic infection; Infection - Other infectious diseases

• Registration Number: ACTRN12622000997752
• Lead Sponsor: niversity Hospital Motol

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-07-15
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Not yet recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

adult patients, patients treatment with voriconazole, agreement with study

Exclusion Criteria

none

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome 1: all-patients treatment with tablet voriconazole , concentration of voriconazole measured using a blood sample<br>voriconazole concentrations will only be assessed by looking at medical records<br>Timepoint: at one year <br>Information regarding analysis of this outcome to determine inter- and intraindividual variability[Baseline 1 year post-intervention commencement ]

Secondary Outcome Measures

Name	Time	Method
liver function tests from medical records - descriptive statistics<br>[Baseline, 1 year after initiation of voriconazole, ];renal function tests from medical records - descriptive statistics<br>[baseline 1 year after initiation of voriconazole]